The effectiveness of the doxorubicin-etoposide-methylprednisolone regimen for adult HLH secondary to rheumatic disease
Crossref DOI link: https://doi.org/10.1007/s00277-024-05796-8
Published Online: 2024-05-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yin, Dongfei
Wang, Jingshi
Wang, Zhao http://orcid.org/0000-0003-1067-4589
Text and Data Mining valid from 2024-05-21
Version of Record valid from 2024-05-21
Article History
Received: 9 April 2024
Accepted: 7 May 2024
First Online: 21 May 2024
Declarations
:
: The authors declare no competing interests.